The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Nature Reviews …, 2010 - nature.com
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Nature Reviews …, 2010 - go.gale.com
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
[引用][C] The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Nature Reviews …, 2010 - cir.nii.ac.jp
The epigenome as a therapeutic target in prostate cancer | CiNii Research CiNii 国立情報学
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Nature reviews …, 2010 - pubmed.ncbi.nlm.nih.gov
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler, D Hollywood - Nature, 2010 - hero.epa.gov
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
The epigenome as a therapeutic target in prostate cancer.
AS Perry, RW Watson, M Lawler… - Nature reviews …, 2010 - europepmc.org
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Journal of Urology, 2010 - pure.qub.ac.uk
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …
The epigenome as a therapeutic target in prostate cancer
AS Perry, RWG Watson, M Lawler… - Nature Reviews …, 2010 - search.proquest.com
During cancer development and progression, tumor cells undergo abnormal epigenetic
modifications, including DNA methylation, histone deacetylation and nucleosome …
modifications, including DNA methylation, histone deacetylation and nucleosome …